Annette Schaub1, Hanns Hippius2, Hans-Jürgen Möller2, Peter Falkai2. 1. Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Munich, Germany Annette.Schaub@med.uni-muenchen.de. 2. Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Munich, Germany.
Abstract
OBJECTIVE: Programs that view individuals as capable of taking an active role in managing their illness have gained importance in Europe and the United States. This article describes the implementation and evaluation of group psychoeducational and cognitive behavioral treatment programs at the Department of Psychiatry and Psychotherapy, Ludwig Maximilian University, Munich, Germany, over the past 20 years. METHODS: Implementing psychoeducational programs was the first step to establish cognitive behavioral psychotherapy and dispel the myth of schizophrenia for patients. Programs are also provided for patients with mood disorders, substance use disorders, or both. These groups include topics such as psychoeducation about the illness, establishing rewarding activities, stress management, cognitive therapy, and relapse prevention. RESULTS: More than 1000 patients with schizophrenia or mood disorders (380 schizophrenia, 563 major depression, and 110 bipolar) have participated in illness management groups to learn about their illness and its treatment, and to learn skills to manage their illness. Patients have expressed satisfaction with the programs, and research has supported their effectiveness. CONCLUSIONS: Individuals with severe disorders can benefit from psychoeducational and cognitive treatment programs if the programs are adapted to the level of neuropsychological functioning and compensate for cognitive deficits and emotional overload. These findings suggest that providing information about the illness and coping skills for patients and relatives are important for treatment outcome.
OBJECTIVE: Programs that view individuals as capable of taking an active role in managing their illness have gained importance in Europe and the United States. This article describes the implementation and evaluation of group psychoeducational and cognitive behavioral treatment programs at the Department of Psychiatry and Psychotherapy, Ludwig Maximilian University, Munich, Germany, over the past 20 years. METHODS: Implementing psychoeducational programs was the first step to establish cognitive behavioral psychotherapy and dispel the myth of schizophrenia for patients. Programs are also provided for patients with mood disorders, substance use disorders, or both. These groups include topics such as psychoeducation about the illness, establishing rewarding activities, stress management, cognitive therapy, and relapse prevention. RESULTS: More than 1000 patients with schizophrenia or mood disorders (380 schizophrenia, 563 major depression, and 110 bipolar) have participated in illness management groups to learn about their illness and its treatment, and to learn skills to manage their illness. Patients have expressed satisfaction with the programs, and research has supported their effectiveness. CONCLUSIONS: Individuals with severe disorders can benefit from psychoeducational and cognitive treatment programs if the programs are adapted to the level of neuropsychological functioning and compensate for cognitive deficits and emotional overload. These findings suggest that providing information about the illness and coping skills for patients and relatives are important for treatment outcome.
Authors: Thomas Frodl; Annette Schaub; Sandra Banac; Marketa Charypar; Markus Jäger; Petra Kümmler; Ronald Bottlender; Thomas Zetzsche; Christine Born; Gerda Leinsinger; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl Journal: J Psychiatry Neurosci Date: 2006-09 Impact factor: 6.186
Authors: Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton Journal: Schizophr Res Date: 2004-12-15 Impact factor: 4.939
Authors: K H Nuechterlein; M E Dawson; M Gitlin; J Ventura; M J Goldstein; K S Snyder; C M Yee; J Mintz Journal: Schizophr Bull Date: 1992 Impact factor: 9.306
Authors: Christoph Born; Larissa de la Fontaine; Bettina Winter; Norbert Müller; Annette Schaub; Clemens Früstück; Cornelius Schüle; Ulrich Voderholzer; Ulrich Cuntz; Peter Falkai; Eva Meisenzahl Journal: BMC Psychiatry Date: 2015-03-24 Impact factor: 3.630